Development and in vivo evaluation of intranasal formulations of parathyroid hormone (1-34)

• Главные авторы: Dan Wang (Автор), Yimeng Du (Автор), Wenpeng Zhang (Автор), Xiaolu Han (Автор), Hui Zhang (Автор), Zengming Wang (Автор), Nan Liu (Автор), Meng Li (Автор), Xiang Gao (Автор), Xiaomei Zhuang (Автор), Jing Gao (Автор), Aiping Zheng (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

For efficient intranasal transport of parathyroid hormone (1-34) [PTH(1-34)], there is a great medical need to investigate permeation enhancers for intranasal formulations. In this study, the development of PTH(1-34) intranasal formulations was conducted. Based on conformation and chemical stability...